Hi suzuki, whatever happens the current IP is definitely not ‘rubbish’ nor likely to disappear and never be ‘seen again’, most especially if apps to become ‘first in its field’.
TAVR still in R&D and a ways to go, ton of comp out there, not sure if this is viable (fanciful thinking) but could a existing TAVR player use this IP to ‘perfect’ or compliment or refine their own?
Current Adapt platform tech earning 10 mill plus, with its expanding and refining portfolio you could reasonably expect this to compound significantly, especially so if in the hands of a major player.
Thats the ‘pot of gold’ Admedus has, .... what absolutely matters to RIs is getting a share of that, SIO will undeniably (and the other cornerstone investor) get the ‘captains’ share, the ‘crew’ (RIs) their much smaller and corresponding share.
How much that portion will be is utterly dependent on the skill of WP to negotiate said deal/s.
Footnote to previous post; the comment that ‘our product is as good as the Admedus one’, they are going to admit it’s better are they? Lol.
AHZ Price at posting:
6.0¢ Sentiment: Hold Disclosure: Held
(20min delay)